Abstract
Eighteen novel N-2,4-dimethoxyphenyl dithiolopyrrolone derivatives inhibiting bacterial RNA polymerase (RNAP) were synthesized based on dithiolopyrrolone scaffold. Some compounds displayed potent antimicrobial activity against Gram-positive bacteria of Staphylococcus aureus and Streptococcus pneumoniae, but not the Gram-negative bacteria of Escherichia coli and Pseudomonas aeruginosa. Moreover, the most promising compound 7b showed potent antibacterial activity against clinical isolates of MRSA, VRSA, RRSA, and MPRSP with MIC values in the range of 0.125–2 μg/mL, and potent inhibitory activity against Escherichia coli RNAP with IC50 value of 19.4 ± 1.3 μM. In addition, compound 7b showed cytotoxicity against LO2 cells with IC50 value of 18.5 ± 1.89 μM. Molecular docking studies revealed that compound 7b interacted with the switch region of the bacterial RNAP. Taken together, compound 7b might serve as a lead structure for developing potent bacterial RNAP inhibitors.
Similar content being viewed by others
References
Campbell EA, Korzheva N, Mustaev A, Murakami K, Nair S, Goldfarb A, Darst SA (2001) Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell 104:901–912
Chopra I (2007) Bacterial RNA polymerase: a promising target for the discovery of new antimicrobial agents. Curr Opin Investig Drugs 8:600–607
Docquier JD, Mangani S (2018) An update on beta-lactamase inhibitor discovery and development. Drug Resist Updat 36:13–29
Furumai R, Matsuyama A, Kobashi N, Lee KH, Nishiyama M, Nakajima H, Tanaka A, Komatsu Y, Nishino N, Yoshida M, Horinouchi S (2002) FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases. Cancer Res 62:4916–4921
Hu T, Schaus JV, Lam K, Palfreyman MG, Wuonola M, Gustafson G, Panek JS (1998) Total synthesis and preliminary antibacterial evaluation of the RNA polymerase inhibitors (±)-myxopyronin A and B. J Org Chem 63:2401–2406
Irschik H, Gerth K, Höfle G, Kohl W, Reichenbach H (1983) The myxopyronins, new inhibitors of bacterial RNA synthesis from Myxococcus fulvus (Myxobacterales). J Antibiot 36:1651–1658
Irschik H, Jansen R, Höfle G, Gerth K, Reichenbach H (1985) The corallopyronins, new inhibitors of bacterial RNA synthesis from Myxobacteria. J Antibiot 38:145–152
Khachatourians GG, Tipper DJ (1974a) In vivo effect of thiolutin on cell growth and macromolecular synthesis in Escherichia coli. Antimicrob Agents Chemother 6:304–310
Khachatourians GG, Tipper DJ (1974b) Inhibition of messenger ribonucleic acid synthesis in Escherichia coli by thiolutin. J Bacteriol 119:795–804
Lamari L, Zitouni A, Boudjella H, Badji B, Sabaou N, Lebrihi A, Lefebvre G, Seguin E, Tillequin F (2002) New dithiolopyrrolone antibiotics from Saccharothrix sp. SA 233. I. Taxonomy, fermentation, isolation and biological activities. J Antibiot 55:696–701
Li B, Lyle MP, Chen G, Li J, Hu K, Tang L, Alaoui-Jamali MA, Webster J (2007) Substituted 6-amino-4H-[1,2]dithiolo[4,3-b]pyrrol-5-ones: synthesis, structure-activity relationships, and cytotoxic activity on selected human cancer cell lines. Bioorg Med Chem 15:4601–4608
Li B, Wever WJ, Walsh CT, Bowers AA (2014a) Dithiolopyrrolones: biosynthesis, synthesis, and activity of a unique class of disulfide-containing antibiotics. Nat Prod Rep 7:905–923
Li C, Sun Y, Wang G, Tan X (2014b) Synthesis of dithiolopyrrolone derivatives and their leukocyte-increasing activities. Bull Korean Chem Soc 35:3489–3494
Li YS, Zhou L, Ma X, Song H, Tang XY (2012) Pharmacophore modeling and structure-based virtual screening for a novel “switch region” target of bacterial RNA polymerase. Med Chem Res 21:642–652
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3–26
Mariani R, Maffioli SI (2009) Bacterial RNA polymerase inhibitors: an organized overview of their structure, derivatives, biological activity and current clinical development status. Curr Med Chem 16:430–454
Meng JY, Huang MH, Lv YB, Tan XD (2019) Synthesis and antibacterial activity of dithiolopyrrolone derivatives. J Int Pharm Res 46:840–847
Molodtsov V, Fleming PR, Eyermann CJ, Ferguson AD, Foulk MA, McKinney DC, Masse CE, Buurman ET, Murakami KS (2015) X-ray crystal structures of Escherichia coli RNA polymerase with switch region binding inhibitors enable rational design of squaramides with an improved fraction unbound to human plasma protein. J Med Chem 58:3156–3171
Mosaei H, Harbottle J (2019) Mechanisms of antibiotics inhibiting bacterial RNA polymerase. Biochem Soc Trans 47:339–350
Moy TI, Daniel A, Hardy C, Jackson A, Rehrauer O, Hwang YS, Zou D, Nguyen K, Silverman JA, Li Q, Murphy C (2011) Evaluating the activity of the RNA polymerase inhibitor myxopyronin B against Staphylococcus aureus. FEMS Microbiol Lett 319:176–179
Mukhopadhyay J, Das K, Ismail S, Koppstein D, Jang M, Hudson B, Sarafianos S, Tuske S, Patel J, Jansen R, Irschik H, Arnold E, Ebright RH (2008) The RNA polymerase “switch region” is a target for inhibitors. Cell 135:295–307
Oliva A, Costantini S, De Angelis M, Garzoli S, Božović M, Mascellino M, Vullo V, Ragno R (2018) High potency of melaleuca alternifolia essential oil against multi-drug resistant Gram-negative bacteria and methicillin-resistant Staphylococcus aureus. Molecules 23:2584
Qin Z, Huang S, Yu Y, Deng H (2013) Dithiolopyrrolone natural products: isolation, synthesis and biosynthesis. Mar Drugs 11:3970–3997
Sahner JH, Groh M, Negri M, Haupenthal J, Hartmann RW (2013) Novel small molecule inhibitors targeting the “switch region” of bacterial RNAP: structure-based optimization of a virtual screening hit. Eur J Med Chem 65:223–231
Sartini S, Levati E, Maccesi M, Guerra M, Spadoni G, Bach S, Benincasa M, Scocchi M, Ottonello S, Rivara S, Montanini B (2019) New antimicrobials targeting bacterial RNA polymerase holoenzyme assembly identified with anin vivo BRET-based discovery platform. ACS Chem Biol 14:1727–1736
Sekiguchi J, Fujino T, Araake M, Toyota E, Kudo K, Saruta K, Kirikae T, Yoshikura H, Kuratsuji T (2006) Emergence of rifampicin resistance in methicillin-resistant Staphylococcus aureus in tuberculosis wards. J Infect Chemother 12:47–50
Tan X, Li C, Yu Z, Wang P, Nian S, Deng Y, Wu W, Wang G (2013) Synthesis of substituted 6-amino-4-(2,4-dimethoxyphenyl)-[1,2]dithiolo[4,3-b]pyrrol-5-ones and their raising leukocyte count activities. Chem Pharm Bull 61:351–357
Wang C, Fang R, Zhou B, Tian X, Zhang X, Zheng X, Zhang S, Dong G, Cao J, Zhou T (2019) Evolution of resistance mechanisms and biological characteristics of rifampicin-resistant Staphylococcus aureus strains selected in vitro. BMC Microbiol 19:220
Wu Y, Ding X, Xu S, Yang Y, Zhang X, Wang C, Lei H, Zhao Y (2019) Design and synthesis of biaryloxazolidinone derivatives containing a rhodanine or thiohydantoin moiety as novel antibacterial agents against Gram-positive bacteria. Bioorg Med Chem Lett 29:496–502
Yakushiji F, Miyamoto Y, Kunoh Y, Okamoto R, Nakaminami H, Yamazaki Y, Noguchi N, Hayashi Y (2013) Novel hybrid-type antimicrobial agents targeting the switch region of bacterial RNA polymerase. ACS Med Chem Lett 4:220–224
Acknowledgements
The work was supported by National Natural Science Foundation of China (No. 81660571), Guangxi Natural Science Foundation of China (No. 2018GXNSFAA281114).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Meng, J., Kong, B., Wang, J. et al. Synthesis and biological evaluation of novel N-2,4-dimethoxyphenyl dithiolopyrrolone derivatives as bacterial RNA polymerase inhibitors. Med Chem Res 29, 1376–1386 (2020). https://doi.org/10.1007/s00044-020-02550-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-020-02550-3